Skip to the page

Data / Drug companies / Uquifa Spain

Uquifa Spain: 28 products in the FDA NDC directory, labeler code 49711

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Uquifa Spain (labeler code 49711) lists 28 products in the FDA National Drug Code Directory. By type: 28 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on November 10, 2025.

The request: Watch Uquifa Spain (FDA labeler code 49711): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
49711
Products in commercial distribution
28
Packages
28
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
2
Earliest marketing start
October 21, 2009
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients28100%

Products by type

TypeProductsShare
Bulk ingredients28100%

Dosage forms

Dosage formProductsShare
Powder28100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Tropicamide49711-1523PowderBulk ingredientsNovember 10, 2025
Ketoconazole49711-1522PowderBulk ingredientsNovember 7, 2025
Bismuth subcitrate potassium49711-1521PowderBulk ingredientsSeptember 5, 2024
Ranolazine micronized49711-1520PowderBulk ingredientsJanuary 27, 2023
Ranolazine49711-1518PowderBulk ingredientsJanuary 27, 2023
Sitagliptin phosphate49711-1519PowderBulk ingredientsJanuary 26, 2023
Emtricitabine49711-1516PowderBulk ingredientsFebruary 19, 2013
Memantine hydrochloride49711-1515PowderBulk ingredientsJuly 30, 2010
Linezolid49711-0121PowderBulk ingredientsJune 7, 2010
Quetiapine fumarate49711-1506PowderBulk ingredientsOctober 26, 2009
Ranitidine hydrochloride form ii49711-0112PowderBulk ingredientsOctober 26, 2009
Omperazole micronized49711-0109PowderBulk ingredientsOctober 26, 2009
Ranitidine hydrochloride49711-0107PowderBulk ingredientsOctober 26, 2009
Robenidine hydrochloride49711-0106PowderBulk ingredientsOctober 26, 2009
Hexyl aminolevulinate hydrochloride49711-1510PowderBulk ingredientsOctober 23, 2009
Hydroxyzine pamoate49711-1508PowderBulk ingredientsOctober 23, 2009
Duloxetine hcl49711-1507PowderBulk ingredientsOctober 23, 2009
Mivacurium chloride 4%49711-1503PowderBulk ingredientsOctober 23, 2009
Doxylamine succinate49711-0114PowderBulk ingredientsOctober 23, 2009
Lansoprazole49711-0110PowderBulk ingredientsOctober 23, 2009
Nimodipine micronized49711-0104PowderBulk ingredientsOctober 23, 2009
Famotidine49711-0098PowderBulk ingredientsOctober 23, 2009
Clindamycin phosphate49711-0116PowderBulk ingredientsOctober 22, 2009
Allopurinol49711-0113PowderBulk ingredientsOctober 22, 2009
Cimetidine49711-0095PowderBulk ingredientsOctober 22, 2009

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.